Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

ONITY GROUP INC. (ONIT)

  • Business News
  • May 05, 2026, 10:45 UTC
  • 0
  • 1 comments

Onity Group Announces First Quarter 2026 Results

Market reaction Comment Full text

APTIV PLC (APTV)

  • Business News
  • May 05, 2026, 10:45 UTC
  • 0
  • 1 comments

Aptiv Reports First Quarter 2026 Financial Results

Market reaction Comment Full text

FERGUSON ENTERPRISES INC. /DE/ (FERG)

  • Business News
  • May 05, 2026, 10:45 UTC
  • 0
  • 1 comments

Ferguson Files Form 8-K

Market reaction Comment Full text

TOPBUILD CORP (BLD)

  • Business News
  • May 05, 2026, 10:45 UTC
  • 0
  • 1 comments

TopBuild Reports First Quarter 2026 Results

Market reaction Comment Full text

SOPHIA GENETICS SA (SOPH)

  • Business News
  • May 05, 2026, 10:45 UTC
  • 0
  • 1 comments

SOPHiA GENETICS Reports First Quarter 2026 Results

Market reaction Comment Full text

FERGUSON ENTERPRISES INC. /DE/ (FERG)

  • Business News
  • May 05, 2026, 10:45 UTC
  • 0
  • 1 comments

Ferguson Reports First Quarter Ended March 31, 2026

Market reaction Comment Full text

LIFE TIME GROUP HOLDINGS, INC. (LTH)

  • Business News
  • May 05, 2026, 10:45 UTC
  • 0
  • 1 comments

Life Time Reports First Quarter 2026 Financial Results

Market reaction Comment Full text

PFIZER INC (PFE)

  • Business News
  • May 05, 2026, 10:45 UTC
  • 0
  • 1 comments

Pfizer Reports Strong First-Quarter Results And Reaffirms 2026 Guidance

Market reaction Comment Full text

Eli Lilly and Company (LLY)

  • Business News
  • May 05, 2026, 10:45 UTC
  • 0
  • 1 comments

Lilly's Omvoh (mirikizumab-mrkz) is the first and only IL-23p19 to demonstrate durable disease clearance in ulcerative colitis through four years

Market reaction Comment Full text

BJ''S WHOLESALE CLUB HOLDINGS, INC. (BJ)

  • Business News
  • May 05, 2026, 10:45 UTC
  • 0
  • 1 comments

BJ’s Wholesale Club Announces First Quarter Fiscal 2026 Earnings Conference Call Date

Market reaction Comment Full text
  • Previous
  • 242
  • 243
  • 244
  • 245
  • 246
  • Next

Search

News categories

  • Technical Exchange News(12339)
  • Event(6229)
  • SEC News(269910)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(157220)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin